The short answer: growth hormone has its own federal crime
Distributing human growth hormone for anti-aging is a federal crime, not a gray area. A specific section of the Food, Drug, and Cosmetic Act, 21 U.S.C. 333(e), makes it an offense to knowingly distribute HGH, or possess it with intent to distribute, for any human use other than treating a disease or recognized medical condition that the FDA has authorized, on a physician’s order.
That wording matters because most medicines are handled differently. Once the FDA approves a drug, licensed clinicians can generally use it off-label when they judge it appropriate. Growth hormone is a rare exception. Congress wrote a statute that limits it to authorized uses, and slowing aging or building muscle is not one of them.
Sermorelin, the peptide often raised as an alternative, is a different molecule that acts at a different step in the body. Knowing that difference, and what it does and does not promise, is the point of this article.
What 21 U.S.C. 333(e) actually says
The statute is short. Here is how its five paragraphs break down.
| Part of the statute | What it covers |
|---|---|
| Paragraph (1) | Knowingly distributing HGH, or possessing it to distribute, for uses outside those the FDA has authorized: up to 5 years in prison, a fine, or both |
| Paragraph (2) | The same offense involving someone under 18: up to 10 years |
| Paragraph (3) | A conviction counts as a felony drug violation for property forfeiture |
| Paragraph (4) | Defines HGH as somatrem, somatropin or an analogue of either |
| Paragraph (5) | Lets the Drug Enforcement Administration investigate |
Two points are easy to miss. First, the law targets distribution: the people who sell, supply or hand out growth hormone for unapproved purposes. Second, the definition is narrow and chemical. It covers somatropin (the recombinant hormone in approved products), somatrem (an older version) and their analogues. It does not name the releasing hormones that tell the pituitary to make growth hormone.
Why anti-aging is not an authorized use
Growth hormone products are approved for specific diagnoses, such as true growth hormone deficiency. Feeling older, carrying more belly fat or recovering slowly from workouts is not a diagnosis on any growth hormone label. The question is not whether some men feel better on it. The law ties legitimate distribution to authorized medical uses, and age alone is not one.
Diagnosing real adult deficiency is also harder than many anti-aging pages suggest. MedlinePlus explains that growth hormone levels swing through the day, which is why IGF-1 is used as a steadier marker, and that confirming deficiency usually involves a stimulation test. It also notes that adult symptoms such as fatigue and lower muscle mass are much more likely to come from other disorders, so growth hormone testing is uncommon in adults.
The practical takeaway: an offer of HGH for “age management” without a documented deficiency falls outside what the statute permits, whoever makes it. If you have already used growth hormone from such a source, tell your clinician, because it changes how your labs are read. Our answer on whether HGH is legal for anti-aging gives the shorter version, and the same legal trap applies to another product category covered in why SARMs are not supplements.
How sermorelin works differently
Sermorelin is a short peptide, 29 amino acids long, that copies the active portion of growth-hormone-releasing hormone (GHRH), the signal your hypothalamus sends to the pituitary. Instead of supplying growth hormone directly, it prompts the pituitary to release its own, in the pulsed rhythm the body already uses.
That design leaves the body’s own brakes in place. The pituitary still answers to feedback signals, so the response is limited by what the gland can and will release. Injected somatropin bypasses those checks, and the level is set by the dose.
| Human growth hormone (somatropin) | Sermorelin | |
|---|---|---|
| What it is | The hormone itself, made recombinantly | A 29-amino-acid GHRH analogue |
| Where it acts | Directly on tissues and the liver | On the pituitary, which then releases growth hormone |
| Feedback limits | Bypassed; level depends on dose | Largely preserved |
| Federal status | Distribution limited to FDA-authorized uses by 21 U.S.C. 333(e) | Formerly approved as Geref; now compounded |
| Tested sport | Prohibited by WADA | Prohibited by WADA |
Sermorelin also has a regulatory history worth knowing. It was approved in 1997 as Geref for children with idiopathic growth hormone deficiency and growth failure, and the manufacturer discontinued it in 2008. In a 2013 Federal Register determination, the FDA concluded that Geref was not withdrawn from sale for reasons of safety or effectiveness. Today sermorelin is compounded, and using it for adult aging or body composition is off-label.
Competitive athletes need one more fact. The World Anti-Doping Agency prohibited list names sermorelin and tesamorelin among growth-hormone-releasing factors and lists growth hormone itself, so both routes are banned in tested sport. Our page on peptides banned for tested athletes covers the rest of that list.
What sermorelin can and cannot promise
Sermorelin is not a legal shortcut to the effects people associate with HGH. Nudging your own growth hormone release is a gentler, more limited intervention, and the evidence for anti-aging benefits in otherwise healthy men is thin. Expect modest changes at most, and judge them by symptoms and lab trends rather than by marketing.
Men who are reasonable candidates tend to share a pattern: symptoms that could plausibly relate to lower growth hormone signaling, an IGF-1 toward the low end for their age, and no condition that makes raising growth signals unwise. A personal history of cancer is one of the first things a provider asks about, because IGF-1 is a growth-promoting signal.
Monitoring matters as much as the starting decision. IGF-1 is the practical marker to follow over time. Our page on IGF-1 levels on sermorelin and tesamorelin explains how results are tracked, and the tesamorelin vs sermorelin comparison covers the FDA-approved alternative, which is used for a narrower purpose.
How Ultimate Male handles growth hormone questions
Human growth hormone is not on the Ultimate Male menu. When men ask about it, the conversation starts with why: energy, recovery, body fat, sleep or a number they saw online. Each of those has more likely causes than growth hormone deficiency, and most of them can be tested.
The path is the one used for every peptide. A free 10-minute phone call comes first, then blood work at our San Gabriel or Downey clinic, including IGF-1, metabolic and hormone markers, with results in 24 to 48 hours. A one-on-one consultation with a PA-C or MD follows. If sermorelin fits, it comes from a licensed U.S. compounding pharmacy, your first injection is shown in the clinic, and follow-up labs and a check-in happen at six to eight weeks.
A consultation is an evaluation, not a promise of a peptide. If your labs point elsewhere, toward testosterone, thyroid or sleep, you will hear that plainly. You can book a visit or first read about growth hormone decline in men.
